Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612672 · ClinicalTrials.gov registry record · NA
Evaluation of GeoHAI Implementation
A NA study of Clostridioides Difficile Infection and Healthcare Associated Infection, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05612672 is a NA study of Clostridioides Difficile Infection and Healthcare Associated Infection that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 25 participants, below the 421-participant average among 6 other Clostridioides Difficile Infection trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05612672, a NA study of Clostridioides Difficile Infection and Healthcare Associated Infection, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but have rarely been applied to the hospital setting. In this study we apply these tools to address the challenge of Hospital Acquired Infections (HAIs) by building, implementing, and evaluating a new computer application which incorporates mapping and geographic data to assist hospital epidemiologists in identifying HAI clusters and assessing transmission risk. We expect that incorporation of geographic information into the workflow of hospital epidemiologists will have a profound effect on our understanding of disease transmission and HAI risk factors in the hospital setting, radically altering the workflow and speed of response of infection preventionists and improving their ability to prevent HAIs.
Conditions Studied
Interventions
- OTHER GeoHAI
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05612672
The ClinicalTrials.gov registry entry for NCT05612672 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 421-participant average among 6 other Clostridioides Difficile Infection trials with a reported enrollment target (94% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Clostridioides Difficile Infection appearing as the primary indexed condition, and to 1 intervention - of which GeoHAI is the first listed.
NCT05612672 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05612672 about?
NCT05612672 is a clinical study titled "Evaluation of GeoHAI Implementation". Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but have rarely been applied to the hospital setting. In this study we apply these tools to address the challenge of Hospital Acquired Infections (HAIs) by building, implementing, and e...
What is the current status of trial NCT05612672?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-02-13. Estimated completion is 2025-09-30.
What conditions does trial NCT05612672 study?
This clinical trial studies the following conditions: Clostridioides Difficile Infection, Healthcare Associated Infection.
What interventions are being tested in trial NCT05612672?
The interventions under investigation include: GeoHAI (OTHER).
Who is sponsoring clinical trial NCT05612672?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05612672 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridioides Difficile Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
RECRUITING · Phase 2
-
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
RECRUITING · Phase 2
-
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
RECRUITING · Phase 3
-
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
RECRUITING · Phase 2
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
COMPLETED
-
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.